Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
Scand J Immunol ; 56(6): 642-4, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12472677

ABSTRACT

Replication of the human immunodeficiency virus type 1 (HIV-1) isolate MN in CEM cells was less neutralized by the plasma from the mothers of infected children (MIC) in comparison with the plasma from the mothers of uninfected children (MUC). Significantly higher neutralization titres were observed for the sera from MUCs compared with MICs, and only the sera from MUC showed 100% neutralization of the HIV-1 MN strain. We suggest that a simple neutralization assay as described here could be useful in prognostic analyses.


Subject(s)
HIV Antibodies/pharmacology , HIV Infections/transmission , HIV-1/immunology , Infectious Disease Transmission, Vertical , Cell Line , Child , Female , HIV Antibodies/blood , HIV Infections/immunology , HIV-1/growth & development , Humans , Neutralization Tests , Virus Replication
2.
Scand J Immunol ; 53(3): 302-9, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11251889

ABSTRACT

Neutralization analyses were carried out with plasma from 132 volunteer human immunodeficiency virus (HIV)-1 infected women (76% pregnant, 24% with infants suspected for HIV-1 infection) collected between 1994 and 1998, against autologous and heterologous primary- and the reference HIV-1 MN isolates. A significantly lower percentage of HIV-1 transmissions was observed after 1996, parallel to a more intense antiretroviral treatment of infected pregnant women. HIV-1 isolation was significantly more frequent from peripheral blood mononuclear cells of mothers of infected children than mothers of uninfected children (P = 0.0065). Neutralization of autologous HIV-1 isolates was comparable for HIV-1 transmitters and nontransmitters' plasma, whereas neutralization of the reference isolate HIV-1 MN was more frequent at high titers for pregnant women who did not transmit HIV to their offspring compared to pregnant women who did. Although neutralization of heterologous primary HIV-1 isolates from HIV transmitters and non transmitters by transmitter plasma occurred with similar frequency, neutralization of isolates from transmitters was much more frequent when heterologous plasma from nontransmitters were used. Macrophage-tropic heterologous HIV-1 isolates were neutralized more frequently at higher titers by plasma from nontransmitters than from transmitters. The results obtained indicate that antiretroviral treatment, lack of success of HIV-1 isolation and high titers of antibodies able to neutralize macrophage-tropic viruses appear to be of importance for protection against HIV-1 vertical transmission for the group of patients studied.


Subject(s)
HIV Antibodies/blood , HIV Infections/immunology , HIV Infections/transmission , HIV-1 , Pregnancy Complications, Infectious/immunology , Adult , Amino Acid Sequence , Antibody Specificity , Female , HIV Envelope Protein gp120/genetics , HIV Envelope Protein gp120/immunology , HIV Infections/complications , HIV-1/genetics , HIV-1/isolation & purification , Humans , Infant , Infant, Newborn , Infectious Disease Transmission, Vertical , Molecular Sequence Data , Neutralization Tests , Peptide Fragments/genetics , Peptide Fragments/immunology , Phenotype , Pregnancy , Pregnancy Complications, Infectious/virology
3.
Mem Inst Oswaldo Cruz ; 93(3): 391-8, 1998.
Article in English | MEDLINE | ID: mdl-9698875

ABSTRACT

Efforts to characterize HIV-1 polymorphism and anti-HIV immune response are being made in areas where anti-HIV/AIDS vaccines are to be employed. Anti-HIV-1 humoral immune response is being studied in infected individuals residents in Rio de Janeiro, in distinct cohorts involving recent seroconvertors, pregnant women or intravenous drug users (IDU). Comparative analyses of specificity of antibody response towards epitopes important for anti-HIV-1 immune response indicate quantitative differences between cohorts, with an exceptionally strong response in IDUs and weakest response in pregnant women. However, a comparative analysis between pregnant women cohorts from Rio de Janeiro and Rio Grande do Sul indicated an even lower response (with exception of the anti-V3-C clade peptide recognition) for the southern cohort. Studies analysing the immune function of the humoral response indicate a quite elevated occurrence of antibodies capable for neutralizing heterologous primary HIV-1 isolates from Rio de Janeiro. Attempts to correlate seroreactivity with HIV-1 neutralization with respect to HIV-1 polymorphism were not very successful: while the Brazilian B clade B " variant could be recognized by binding assays, no significant distinction of HIV-1 clades/variants was observed in viral neutralization assays.


Subject(s)
Antibody Formation/immunology , Antibody Specificity , HIV Antibodies/immunology , HIV Infections/immunology , HIV-1/immunology , Brazil , Cohort Studies , Female , Genotype , HIV Antibodies/genetics , HIV Infections/genetics , HIV Infections/transmission , Humans , Male , Neutralization Tests , Pregnancy
4.
J Acquir Immune Defic Syndr Hum Retrovirol ; 18(5): 488-94, 1998 Aug 15.
Article in English | MEDLINE | ID: mdl-9715846

ABSTRACT

HIV-1-positive individuals were recruited from January 1993 to December 1996 from several cohorts receiving follow-up in the city of Rio de Janeiro, Brazil, to evaluate HIV-1 genetic variability and the potential association with modes of transmission. HIV-1 subtyping was carried out using the heteroduplex mobility assay (HMA), and those samples corresponding to the typical Brazilian subtype B variant were further identified based on the Fok I restriction fragment length polymorphism (RFLP). DNA sequencing was performed to evaluate one case of subtype D infection. From the 131 HIV-1-positive individuals analyzed, 106 (80.9%) could be identified as infected by subtype B and 20 (15.3%) by subtype F. One of the samples (0.8%) was classified as subtype D. DNA samples from 4 patients (3.0%) did not yield polymerase chain reaction (PCR)-amplified products to be typed. Based on the Fok I RFLP, 39 of the 106 subtype B samples (37%) were identified as corresponding to the typical Brazilian subtype B variant containing the GWGR motif at the tip of the V3 loop. No statistically significant association could be detected between HIV-I subtypes and modes of transmission, exposure categories, or gender. This is the first reported case of HIV-1 subtype D infection in Brazil.


Subject(s)
HIV Infections/epidemiology , HIV-1/classification , Amino Acid Sequence , Brazil/epidemiology , Cohort Studies , Consensus Sequence , DNA, Viral/chemistry , Female , Gene Products, env/chemistry , Gene Products, env/genetics , Genetic Variation , HIV Infections/transmission , HIV Infections/virology , HIV-1/genetics , Humans , Male , Molecular Epidemiology , Molecular Sequence Data , Nucleic Acid Heteroduplexes , Phylogeny , Polymerase Chain Reaction , Polymorphism, Restriction Fragment Length , Prevalence , Sequence Alignment , Sex Distribution , Urban Population
5.
Scand J Immunol ; 47(6): 603-8, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9652830

ABSTRACT

Susceptibility to autologous and heterologous neutralization of primary human immunodeficiency virus (HIV)-1 isolates belonging to subtype B, to the B"-variant of subtype B or to subtype F from infected individuals residing in Rio de Janeiro was assayed. A lower infectivity of the B"- and F isolates when compared to the classical B-subtype HIV-1 isolates was observed. Comparisons of neutralization susceptibilities were carried out for 19 B-subtype, 11 B"-variant and two F-subtype HIV-1 isolates with plasma from autologous and heterologous samples. Frequency of autologous neutralization was slightly lower for B-subtype isolates in comparison to B"-variant isolates. Heterologous intra-subtype neutralization was significantly lower for B-subtype than for the B"-variant or the F-subtype isolates. While B-subtype isolates were neutralized by most anti-F-subtype plasma, F-subtype isolates, although most susceptible to F-subtype antibodies, were highly susceptible to neutralization by anti-B-subtype antibodies. Cross-neutralization for B"-variant and B-subtype isolates was not as extensive as observed for B- and F-subtype isolates. However, the results presented indicate a quite extensive cross-neutralization between Brazilian HIV-1 isolates.


Subject(s)
HIV Antigens/immunology , HIV-1/immunology , Antigenic Variation , HIV Antibodies/immunology , HIV-1/isolation & purification , Humans , Neutralization Tests
6.
Mem. Inst. Oswaldo Cruz ; 93(3): 391-8, May-Jun. 1998. tab, graf
Article in English | LILACS | ID: lil-209963

ABSTRACT

Efforts to characterize HIV-1 polymorphism and anti-HIV immune response are being made in areas where anti-HIV/AIDS vaccines are to be employed. Anti-HIV-1 humoral immune response is being studied in infected individuals resident in Rio de Janeiro, in distinct cohorts involving recent seroconvertors, pregnant women or intravenous drug users (IDU). Comparative analysis of specificity of antibody response towards epitopes important for anti-HIV-1 immune response indicate quantitative differences between cohorts, with an exceptionally strong response in IDUs and weakest response in pregnant women. However, a comparative analysis between pregnant women cohorts from Rio de Janeiro and Rio Grande do Sul indicated an even lower response (with exception of the anti-V3-C clade peptide recognition) for the southern cohort. Studied analysing the immune function of the humoral response indicate a quite elevated occurrence of antibodies capable of neutralizing heterologous primary HIV-1 isolates from Rio de Janeiro. Attempts to correlate seroreactivity with HIV-1 neutralization with respect to HIV-1 polymorphism were not very successfull: while the Brazilian B clade B" variant could be recognized by binding assays, no significant distinction of HIV-1 clades/variants was observed in viral neutralization assays.


Subject(s)
Humans , Antibody Formation , Antibody Specificity/immunology , Genotype , HIV-1/immunology , Brazil , Cohort Studies , HIV Seropositivity/immunology
7.
AIDS ; 11(8): 969-75, 1997 Jul.
Article in English | MEDLINE | ID: mdl-9223730

ABSTRACT

OBJECTIVE: To study the susceptibility of primary HIV-1 isolates towards autologous and heterologous neutralizing antibodies (NAb). DESIGN: Blood was collected and primary HIV-1 isolated from individuals residing in Rio de Janeiro, Brazil, in all phases of disease. METHODS: Primary HIV-1 isolates were incubated with autologous or heterologous plasma and neutralization of infection of freshly pre-stimulated normal human peripheral blood mononuclear cells was assayed in parallel to median infectious dose determinations in the absence of antibodies. Levels of HIV-1 p24 antigen were used for evaluation of viral neutralization. RESULTS: Autologous neutralization (75%) was observed for 13 (52%) out of 25 of the primary HIV-1 isolates, and 15 (71%) out of 21 isolates were susceptible to 75% heterologous neutralization by at least one-half of the heterologous plasma tested. Primary HIV-1 isolates susceptible to autologous NAb showed a higher susceptibility towards neutralization by heterologous NAb than isolates that could not be neutralized by the autologous plasma (P = 0.049). The susceptibility of the primary HIV-1 isolates towards neutralization by heterologous NAb was significantly higher for isolates derived from men (P = 0.001), and for isolates obtained from individuals infected through homo-/bisexual risk behaviour in comparison with those infected through heterosexual HIV-1 transmission (P = 0.03). CONCLUSIONS: Susceptibility of primary HIV-1 isolates to autologous and heterologous neutralization was significantly correlated, indicating that escape mutants may become resistant not only to autologous but also to heterologous NAb.


Subject(s)
HIV Antibodies/immunology , HIV Seropositivity/immunology , HIV-1/immunology , Adolescent , Adult , Animals , Female , Goats , HIV Core Protein p24/analysis , HIV Envelope Protein gp120/immunology , HIV Seropositivity/blood , HIV Seropositivity/virology , HIV-1/classification , HIV-1/isolation & purification , Humans , Leukocytes, Mononuclear/immunology , Leukocytes, Mononuclear/virology , Male , Middle Aged , Neutralization Tests , Peptide Fragments/immunology
14.
Rev. bras. ortop ; 17(6): 236-8, 1982.
Article in Portuguese | LILACS | ID: lil-13364

ABSTRACT

Os autores apresentam um caso de fascite eosinofilica, o primeiro em nosso pais, com dados clinicos e laboratoriais, incluindo estudo anatomo-patologico. Os achados sao discutidos a luz dos trabalhos publicados nos periodicos estrangeiros desde a descricao da molestia por Shulman em 1974


Subject(s)
Adolescent , Humans , Female , Eosinophilia , Fasciitis , Diagnosis, Differential
SELECTION OF CITATIONS
SEARCH DETAIL
...